The lawsuit, which was filed in the US District Court for the Northern District of Florida, argues that Florida’s ban violates the Constitution’s provisions that prohibit protectionist measures designed to favor in-state businesses at the expense of out-of-state competitors. 

The breakthrough will enable the company to produce cultivated meat significantly faster and at lower costs than industry norms, and is therefore an important step towards the commercialization of Meatable’s technology and large-scale production of cultivated meat products more broadly.

At a time that the plant-based meat analog industry is currently passing through some growing pains, cell-based meat is encountering its own challenges.

In this interview with Prepared Foods, Eyal Rosenthal, CEO of Ever After Foods, Ltd., discusses the company’s advancements in cell-based meat production. Learn how Ever After's technology eschewed the industry standard and is able to produce a high volume, so-far comparatively low cost product.

Meat alternatives could be developed in future iterations to gain nutritional value that matches or exceeds that of traditional meat.

The $999,967 two-year grant is a testament to Novel Farms' work in the field of cultivated meat production and will provide critical funding to support the scale-up of their proprietary scaffolding platform. 

These strategic appointments underscore UPSIDE's dedication to assembling an exceptional industry-defining leadership team to drive the company's growth in its next phase.

The fund announcement comes on the heels of the landmark USDA approval of cell-cultivated meat to US consumers last week.

The moment for the burgeoning cultivated meat, poultry and seafood sector, and for the global food industry, comes on the heels of the USDA’s approval of GOOD Meat’s label – and four months after the company received its “no questions” letter from the US Food and Drug Administration.

With an approved label in hand, UPSIDE Foods is now working with USDA to obtain a Grant of Inspection (GOI) for its Engineering, Production, and Innovation Center (EPIC), the last remaining item in the pre-market regulatory process before the company can commercially produce and sell its cultivated chicken in the United States.